Skip to content

Ayurvedic treatment of hypothyroidism with help of Nano kanchanar

Randomised double blind,placebo controlled evaluation of NANO KANCHANAR (Bauhinia variegata Linn)HYDRO ALCOHOLIC EXTRACT in HYPOTHYROIDISM

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047606
Enrollment
63
Registered
2022-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

None listed

Sponsors

Dean Faculty Of Ayurved Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Age: From 18 Year(s) Age To 60 Year(s) (inclusive of either age) b) Gender: Both c) Patients already diagnosed as hypothyroidism with/without medication d) Patients with primary hypothyroidism e) Patients with subclinical hypothyroidism

Exclusion criteria

Exclusion criteria: a) Patients who have undergone any type of thyroid surgery. b) Patients suffering from systemic diseases like IHD, PCOD, uncontrolled Diabetes Mellitus, uncontrolled HTN c) Immuno compromised diseases like HIV etc. d) Patients suffering from congenital hypothyroidism e) Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
to study adjuvant effect of nano Kanchnar (Bauhinia variegata Linn) hydro-alcoholic extract in comparison with placebo on the basis of T3,T4,TSH levels in management of hypothyroidismTimepoint: T3,T4,TSH levels at baseline and at the 12 weeks.

Secondary

MeasureTime frame
to study adjuvant effect of nano Kanchnar (Bauhinia variegata Linn) hydro-alcoholic extract in comparison with placebo on the basis of standard gradation scale and Billewicz index for hypothyroidism in management of hypothyroidism at 4weeks,8weeks,12weeks.Timepoint: lipid profile at baseline and at the 12 weeks billewicz index for hypothyroidism at baseline and at the end of every visit.

Countries

India

Contacts

Public ContactDr Vaishali S Deshpande

parul institute of ayurveda

dr.shaileshd@gmail.com9763104451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026